Designing HepCare App: Promoting Hepatitis Prevention and Awareness in Bangladesh
Mst. Shikha Khatun, Anikah Hossain, Sumaiya Akter, Md Abu Sayed, Ashraful Islam, M. Ashraful Amin
Human-Centered Design, Operation and Evaluation of Mobile Communications
Springer Nature Switzerland, pp. 300–318, ISBN: 978-3-031-93061-4
Abstract
Hepatitis remains a major public health concern in Bangladesh due to a lack of awareness, inadequate access to healthcare, and low vaccination rates. In response to these challenges, the `HepCare' app has been designed, aiming to promote hepatitis prevention and awareness across Bangladesh. The app is expected to play a crucial role in reducing the country's high rates of viral hepatitis. The User-Centered Design (UCD) methodology is used in this study to create a mobile health (mHealth) application (app) `HepCare' that is tailored specifically for Bangladeshi people. The `HepCare' app seeks to offer comprehensive information on any type of hepatitis, including prevention techniques, and modes of transmission. So the research objectives include conducting a needfinding analysis and developing low and high-fidelity prototypes of the `HepCare' app. Key functionalities of the `HepCare' app include ``About the Types of Hepatitis'', ``Prevention Guidelines From Online Resources'', ``People at Risk'', ``Chatbox'', ``Guidelines for Living With Hepatitis'', ``Symptoms Tracker'', ``Medication Reminder'', ``Doctor's Appointment Reminder'', ``Pregnancy and Hepatitis'', and ``Advertisement and Awareness''. Interactive elements, like ``Chatbox'', encourage participation and lessen stigma. Moreover, 91.2% of participants expressed willingness to use and recommend the `HepCare' app during a user study. The user-friendly design of the high-fidelity prototype ensures intuitive interaction, becoming a vital resource in the fight against hepatitis in Bangladesh, empowering individuals with the information and resources.
CCDS Authors
References
- 1.David J. Pinato, Rohini Sharma, Elias Allara, Clarence Yen, Tadaaki Arizumi, Keiichi Kubota, Dominik Bettinger, Jeong Won Jang, Carlo Smirne, Young Woon Kim, Masatoshi Kudo, Jessica Howell, Ramya Ramaswami, Michela Emma Burlone, Vito Guerra, Robert Thimme, Mitsuru Ishizuka, Justin Stebbing, Mario Pirisi, Brian I. Carr. (2016). The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. Journal of Hepatology, 66(2), 338–346[10.1016/j.jhep.2016.09.008]
- 2.Marc Ringehan, Jane A. McKeating, Ulrike Protzer. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B Biological Sciences, 372(1732), 20160274[10.1098/rstb.2016.0274]
- 3.Yi-Tsung Lin, Fu‐Der Wang, Yu‐Jiun Chan, Yung-Chieh Fu, Chang-Phone Fung. (2014). Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniaebacteremia in Taiwan. BMC Infectious Diseases, 14(1), 1[10.1186/1471-2334-14-1]
- 4.Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico. (2021). Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut, 70(9), 1782–1794[10.1136/gutjnl-2020-323888]
- 5.Andrew S. Azman, Kishor Kumar Paul, Taufiqur Rahman Bhuiyan, Aybüke Koyuncu, Henrik Salje, Firdausi Qadri, Emily S. Gurley. (2021). Hepatitis E in Bangladesh: Insights From a National Serosurvey. The Journal of Infectious Diseases, 224(Supplement_7), S805–S812[10.1093/infdis/jiab446]
- 6.Sujan Banik, Anamika Datta, Antara Ghosh, Kanak Yadab Ghosh, Hoimonti Debi. (2022). The prevalence of hepatitis B virus infection in Bangladesh: a systematic review and meta-analysis. Epidemiology and Infection, 150, e47[10.1017/s0950268822000061]
- 7.Chul S. Hyun, Joseph P. McMenamin, Okhyun Ko, Soonsik Kim. (2020). Efficacy of a Mobile Texting App (HepTalk) in Encouraging Patient Participation in Viral Hepatitis B Care: Development and Cohort Study. JMIR mhealth and uhealth, 8(4), e15098[10.2196/15098]
- 8.Mamun Al-Mahtab. (2016). Past, Present, and Future of Viral Hepatitis in Bangladesh. Euroasian Journal of Hepato-Gastroenterology, 6(1), 43–44[10.5005/jp-journals-10018-1164]
